The marketplace is now getting it right.
Storytime is over.
If they deliver on the stated intentions - the share price will go up.
If they continue with the possibilities and stories the share price will remain neutral or decline.
Using COVID as a potential catalyst to ignite the app's performance is drawing a longbow.
Ann: First patients recruited in COVID-19 clinical study in India, page-86
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
